01Overview 02Daily Brief 03Live 04Congress 05Corporate Insiders 06Government Money 07Political Influence 08Institutions 09Washington Network 10Follow the Power 11Disclosure Clock 12AI Investigator 13Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

01Overview 02Daily Brief 03Live 04Congress 05Corporate Insiders 06Government Money 07Political Influence 08Institutions 09Washington Network 10Follow the Power 11Disclosure Clock 12AI Investigator 13Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Overview Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

SEC FORM 428m ago

HOUSE PTR28m ago

SEC 13F28m ago

ROBINHOOD CHAIN28m ago

Public company

URGNUroGen Pharma Ltd.

CIK 0001668243

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections2with evidence

URGN · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Lobbied forevidence
BGR GOVERNMENT AFFAIRSLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026

Lobbying

$60K reported · de-duplicated

2026 Q2 $30K via firms2026 Q1 $30K via firms

BGR GOVERNMENT AFFAIRS$30K2026 Q1 · posted Aug 26, 2026 ·
BGR GOVERNMENT AFFAIRS$30K2026 Q2 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.